These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3023615)

  • 1. Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I.
    Wallis G; Beighton P; Boyd C; Mathew CG
    J Med Genet; 1986 Oct; 23(5):411-6. PubMed ID: 3023615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of molecular haplotypes specific for the human pro alpha 2(I) collagen gene in linkage analysis of the mild autosomal dominant forms of osteogenesis imperfecta.
    Falk CT; Schwartz RC; Ramirez F; Tsipouras P
    Am J Hum Genet; 1986 Mar; 38(3):269-79. PubMed ID: 3006479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta.
    Tsipouras P; Børresen AL; Dickson LA; Berg K; Prockop DJ; Ramirez F
    Am J Hum Genet; 1984 Nov; 36(6):1172-9. PubMed ID: 6097110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.
    Tsipouras P; Myers JC; Ramirez F; Prockop DJ
    J Clin Invest; 1983 Oct; 72(4):1262-7. PubMed ID: 6313757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segregation analysis of dominant osteogenesis imperfecta in Italy.
    Mottes M; Cugola L; Cappello N; Pignatti PF
    J Med Genet; 1990 Jun; 27(6):367-70. PubMed ID: 1972760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta.
    Grobler-Rabie AF; Wallis G; Brebner DK; Beighton P; Bester AJ; Mathew CG
    EMBO J; 1985 Jul; 4(7):1745-8. PubMed ID: 2992938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.
    Pihlajaniemi T; Dickson LA; Pope FM; Korhonen VR; Nicholls A; Prockop DJ; Myers JC
    J Biol Chem; 1984 Nov; 259(21):12941-4. PubMed ID: 6092353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.
    Wenstrup RJ; Tsipouras P; Byers PH
    J Clin Invest; 1986 Dec; 78(6):1449-55. PubMed ID: 3782466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.
    Superti-Furga A; Pistone F; Romano C; Steinmann B
    J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
    Cohn DH; Byers PH; Steinmann B; Gelinas RE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6045-7. PubMed ID: 3016737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Stacey A; Bateman J; Choi T; Mascara T; Cole W; Jaenisch R
    Nature; 1988 Mar; 332(6160):131-6. PubMed ID: 2450280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ
    Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of the alpha 1(II) cartilage collagen gene as the mutant locus in type IA osteogenesis imperfecta.
    Sykes B; Smith R; Vipond S; Paterson C; Cheah K; Solomon E
    J Med Genet; 1985 Jun; 22(3):187-91. PubMed ID: 2989526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta.
    Dickson LA; Pihlajaniemi T; Deak S; Pope FM; Nicholls A; Prockop DJ; Myers JC
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4524-8. PubMed ID: 6087329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2.
    Sykes B; Ogilvie D; Wordsworth P; Wallis G; Mathew C; Beighton P; Nicholls A; Pope FM; Thompson E; Tsipouras P
    Am J Hum Genet; 1990 Feb; 46(2):293-307. PubMed ID: 1967900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
    Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
    Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of osteogenesis imperfecta and related disorders of bone.
    Prockop DJ; Kuivaniemi H; Tromp G
    Clin Plast Surg; 1994 Jul; 21(3):407-13. PubMed ID: 7924138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC; Pruchno CJ; Byers PH
    Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction fragment length polymorphisms.
    Tsipouras P
    Methods Enzymol; 1987; 145():205-13. PubMed ID: 2885721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.